Aromatase inhibitors and the syndrome of arthralgias with estrogen deprivation
Open Access
- 2 September 2005
- journal article
- review article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 52 (9) , 2594-2598
- https://doi.org/10.1002/art.21364
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast CancerNew England Journal of Medicine, 2004
- A Randomized Trial of Letrozole in Postmenopausal Women after Five Years of Tamoxifen Therapy for Early-Stage Breast CancerNew England Journal of Medicine, 2003
- Effects of long‐term estrogen replacement therapy on osteoarthritis severity in cynomolgus monkeysArthritis & Rheumatism, 2002
- Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trialThe Lancet, 2002
- Sex hormonal factors and chronic widespread pain: a population study among womenRheumatology, 2002
- Sex hormones and pain: A new role for brain aromatase?Journal of Comparative Neurology, 2000
- Estrogen and Osteoarthritis: How Do We Explain Conflicting Study Results?Preventive Medicine, 1999
- Estrogen and progesterone activate spinal kappa-opiate receptor analgesic mechanismsPain, 1996
- The prevalence and characteristics of fibromyalgia in the general populationArthritis & Rheumatism, 1995
- Aromatase inhibitors and their potential clinical significanceJournal of Steroid Biochemistry, 1986